Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research

Front Endocrinol (Lausanne). 2021 Nov 30:12:781105. doi: 10.3389/fendo.2021.781105. eCollection 2021.

Authors

Wan-Chen Wu¹, Qiang Wei², Vin-Cent Wu³

Affiliations

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
² Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
³ Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.

No abstract available

Keywords: APCCs; CYP11B2; MRA; adrenal venous sampling; primary aldosteronism.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Humans
Hyperaldosteronism / diagnosis*
Hyperaldosteronism / genetics
Hyperaldosteronism / therapy*
Mineralocorticoid Receptor Antagonists / therapeutic use
Translational Research, Biomedical / methods
Translational Research, Biomedical / trends*
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Mineralocorticoid Receptor Antagonists